Our Press Releases | Association for Accessible Medicines

New Blog - Inflation Rebate Proposal Builds on Bad Policy for Generics

Doesn't Add Up patient photo

Nov 19, 2021 | Rachel Schwartz

Association for Accessible Medicines Warns Build Back Better Act Threatens Patient Access

Dr. Robert Califf

Nov 12, 2021 | Rachel Schwartz

AAM Statement on the Nomination of Dr. Robert Califf to Lead FDA

Nov 10, 2021 | Rachel Schwartz

Paula Witt Joins AAM as Senior Manager, State Government Affairs

Misguided Drug Pricing Reform

Nov 2, 2021 | Rachel Schwartz

AAM Opposes Latest Prescription Drug Reform Framework

Second Annual Global Biosimilars Week #GlobalBiosimilarsWeek

Oct 31, 2021 | Rachel Schwartz

Biosimilars Council Encourages Stakeholders, Advocates to Join #GlobalBiosimilarsWeek

Bureau of Legislative Affairs

Oct 27, 2021 | Rachel Schwartz

Kenneth Westberry Joins AAM As Senior Manager, State Government Affairs

Oct 6, 2021 | Rachel Schwartz

Christine Simmon Named Executive Vice President, Policy and Strategic Alliances for the Association for Accessible Medicines

Pharmacist talking to a patient at a pharmacy

Sep 21, 2021 | Rachel Schwartz

Study Finds U.S. Generic and Biosimilar Savings Totaled A Record $338 Billion in 2020

Drug manufacture

Sep 13, 2021 | Rachel Schwartz

Scott Kuzner Joins AAM As Senior Director, Sciences and Regulatory Affairs

Sep 13, 2021 | Rachel Schwartz

Polly Webster Joins AAM As Vice President, Federal Affairs

Press Release: HHS 45-Day Plan to Lower the Cost of Prescription Drugs

Sep 9, 2021 | Rachel Schwartz

AAM Statement on HHS 45-Day Plan to Lower the Cost of Prescription Drugs

AAM Calls for Increased Voluntary Licensing of Covid Vaccine

Aug 16, 2021 | Rachel Schwartz

AAM Calls for Increased Voluntary Licensing of Covid Vaccines to Increase Patient Access